Implantable Device Targets Pancreatic Tumors

Researchers from MIT and Massachusetts General Hospital have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumors. Using mice, the team determined that the implant approach was up to 12 times more effective than the common method of delivering chemotherapy drugs by intravenous injection.